VII. Are lymphomas driven by epigenetic lesions? (Q38523987)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on June 2015

Language	Label	Description	Also known as
English	VII. Are lymphomas driven by epigenetic lesions?	scientific article published on June 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

VII. Are lymphomas driven by epigenetic lesions? (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Isaac W Boss

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Ari M Melnick

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

1 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hematological Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

33 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

42-45

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Translating the Histone Code

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Genetics of follicular lymphoma transformation

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Control of developmental regulators by Polycomb in human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Analysis of the coding genome of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHON.2215

21 January 2018

Identifiers

10.1002/HON.2215

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38523987&oldid=1508428382"